Otsuka (OTSKY) Stock Price, News & Analysis

Company Overview

Otsuka Holdings Co., Ltd. is a Japan-based healthcare company that manages a group of businesses focused primarily on pharmaceuticals, nutraceuticals, and consumer health products. Through its subsidiaries, the company researches, develops, manufactures, and markets prescription medicines, over-the-counter products, functional foods, and beverages.

Its pharmaceutical operations address areas including psychiatry, oncology, cardiovascular and renal diseases, and several other specialty conditions. Otsuka’s well-known consumer health and nutrition brands include Pocari Sweat, a sports drink, and CalorieMate, a nutritionally balanced food product. The group also operates businesses involved in medical devices, diagnostics, and pharmaceutical manufacturing.

Founded in Japan in 1964, Otsuka Holdings serves customers in Japan and international markets through a global network of research, production, and commercial operations. The company’s businesses are led through its corporate holding structure and include Otsuka Pharmaceutical, Taiho Pharmaceutical, Otsuka Pharmaceutical Factory, and other affiliated companies.

Key Stats

• Today's Range: $36.92 to $37.21
• 50-Day Range: $34.88 to $39.65
• 52-Week Range: $26.11 to $40.92
• Volume: 18,184 shs
• Average Volume: 41,261 shs
• Market Capitalization: $39.66 billion
• P/E Ratio: 15.85
• Dividend Yield: 1.00%
• Price Target: N/A
• Consensus Rating: Moderate Buy

Otsuka Stock Analysis - MarketRank™

Otsuka scored higher than 58% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.5 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Otsuka has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, 1 buy rating, 1 hold rating, and 1 sell rating.

Amount of Analyst Coverage

Otsuka has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 6.33%

Earnings Growth

Earnings for Otsuka are expected to grow by 6.33% in the coming year, from $2.21 to $2.35 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Otsuka is 15.85, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 27.02.

Price to Earnings Ratio vs. Sector

The P/E ratio of Otsuka is 15.85, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 36.88.

Price to Earnings Growth Ratio

Otsuka has a PEG Ratio of 2.76. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Otsuka has a P/B Ratio of 1.91. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.01% of the float of Otsuka has been sold short.

Short Interest Ratio / Days to Cover

Otsuka has a short interest ratio ("days to cover") of 0.74, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Otsuka has recently increased by 45.81%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Otsuka has a dividend yield of 0.97%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Otsuka does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Otsuka is 15.88%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Otsuka will have a dividend payout ratio of 15.74% next year. This indicates that Otsuka will be able to sustain or increase its dividend.

News and Social Media

• Score: 4.4 / 5
• News Sentiment: N/A

News Sentiment

Otsuka has a news sentiment score of 3.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.66 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Otsuka this week, compared to 0 articles on an average week.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Otsuka insiders have not sold or bought any company stock.

Percentage Held by Institutions

Otsuka has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 10/30/2026
• Today: 11/03/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:OTSKY
• Previous Symbol: OTCMKTS:OTSKY
• CIK: 1544613
• Web: www.otsuka.com
• Phone: (136) 717-1410
• Fax: N/A
• Employees: 37,758
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $2.33
• Trailing P/E Ratio: 15.85
• Forward P/E Ratio: 15.71
• P/E Growth: 2.76
• Net Income: $2.43 billion
• Net Margins: 15.50%
• Pretax Margin: N/A
• Return on Equity: 12.86%
• Return on Assets: 9.59%

Debt

• Debt-to-Equity Ratio: 0.05
• Current Ratio: 2.21
• Quick Ratio: 1.65

Sales & Book Value

• Annual Sales: $16.51 billion
• Price / Sales: 2.40
• Cash Flow: $2.87 per share
• Price / Cash Flow: 12.86
• Book Value: $19.33 per share
• Price / Book: 1.91

Miscellaneous

• Outstanding Shares: 1,074,190,000
• Free Float: N/A
• Market Cap: $39.66 billion
• Optionable: Not Optionable
• Beta: 0.09